Liver Fatty Acid-binding Protein Is A Diagnostic Marker to Detect Liver Injury Due to Chronic Hepatitis C Infection
- 1 January 2013
- journal article
- Published by Elsevier BV in Archives of Medical Research
- Vol. 44 (1), 34-38
- https://doi.org/10.1016/j.arcmed.2012.11.007
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infectionJournal of Viral Hepatitis, 2009
- Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patientsHepatology, 2008
- Can We Predict the Degree of Fibrosis in Chronic Hepatitis C Patients Using Routine Blood Tests in Our Daily Practice?Journal of Clinical Gastroenterology, 2008
- Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminasesJournal of Viral Hepatitis, 2007
- Review article: management of patients with chronic hepatitis C virus infection and ‘normal’ alanine aminotransferase activityAlimentary Pharmacology & Therapeutics, 2006
- Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 yearsJournal of Viral Hepatitis, 2006
- Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy?Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2005
- Chronic hepatitis C with normal aminotransferase levelsGastroenterology, 2004
- Cellular fatty acid-binding proteins: Their function and physiological significanceProgress in Lipid Research, 1996
- Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus InfectionNew England Journal of Medicine, 1996